查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1965969

可吸收聚合物市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、應用、區域和競爭格局分類，2021-2031年

Resorbable Polymers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球可吸收（生物可吸收）聚合物市場預計將從 2025 年的 4.8343 億美元成長到 2031 年的 6.4452 億美元，複合年成長率為 4.91%。

這些特殊的生物分解材料旨在人體內安全分解，有效避免組織癒合後再次手術取出金屬植入物。推動這一市場成長的關鍵因素包括全球人口老化導致慢性病發病率上升，以及微創醫療技術的日益普及。在整形外科固定和控釋藥物等應用中，這些聚合物可在人體自然代謝前提供臨時結構支撐，從而展現出比永久性金屬植入更顯著的臨床優勢。

市場概覽
預測期 2027-2031
市場規模：2025年 4.8343億美元
市場規模：2031年 6.4452億美元
複合年成長率：2026-2031年 4.91%
成長最快的細分市場 整形外科
最大的市場 北美洲

儘管需求依然強勁，但醫用級認證所需的嚴格且高成本的監管程序仍構成重大障礙。製造商必須遵守複雜的合規框架，這往往會導致產品商業化進程的延遲。根據歐洲生質塑膠協會預測，到2024年，包括聚乳酸等重要吸收材料在內的全球生質塑膠產能將達到約247萬噸。這一數字顯示供應鏈穩健，但嚴格的臨床檢驗要求仍限制創新聚合物技術在醫療領域的應用速度。

市場促進因素

從金屬醫療植入向生物可吸收植入的轉變正在從根本上改變市場格局，因為它消除了取出等二次手術的必要性。由於這些聚合物可在體內無害分解，因此避免了鈦和鋼植入通常需要的後續取出手術所帶來的臨床風險和醫療成本。這一顯著的臨床優勢正在推動其在運動醫學和整形外科固定領域的廣泛應用，在這些領域，臨時加固足以促進骨骼恢復。為了支持這項不斷成長的產業需求，Corbion 在 2024 年 3 月發布的 2023 會計年度年度報告中指出，其生物醫用聚合物部門維持了兩位數的成長，凸顯了創傷治療和緩釋應用領域對生物可吸收材料日益成長的需求。

同時，支架技術和3D生物列印技術的進步正推動市場成長，因為它們能夠生產高度個人化的組織結構。先進的積層製造技術可以製造出多孔、可吸收的結構，這些結構旨在模擬天然軟組織，並在代謝之前促進再生。根據BellaSeno公司2024年8月發布的關於其臨床計畫的媒體稿，該公司使用3D列印的可吸收支架成功治療了41名患者，證明了這些新一代植入的安全性和有效性。更廣泛的產業格局也支持這種擴充性；根據塑膠工業協會2024年的估計，光是北美就佔全球生質塑膠產能的18.7%，這確保了這些快速成長的醫療技術所需的可靠材料供應。

市場挑戰

獲得醫用級認證所需的高成本和繁瑣的監管流程是全球可吸收（生物可吸收）聚合物市場擴張的主要障礙。製造商必須應對日益複雜的合規環境，尤其是在要求提供全面技術文件和臨床數據的嚴格框架下。這種監管狀況給新型聚合物醫療設備帶來了沉重的經濟負擔，並延長了產品上市時間。這直接阻礙了創新，並使缺乏資金來應對這些漫長流程的中小型企業難以進入市場。

這些更嚴格標準的影響是嚴重且可量化的。據歐洲醫療技術協會（MedTech Europe）稱，根據醫療設備法規（MDR），到2024年，認證和維修成本將比先前的指令高出100%。成本的急劇上升和顯著的延誤迫使各機構將資金從研發活動重新分配到合規義務。因此，儘管臨床對這些材料有需求，但先進吸收性聚合物技術的應用卻被延緩，限制了商業性化供應，並抑制了整體市場發展動能。

市場趨勢

可吸收聚合物在永續包裝領域的應用正蓬勃發展，其應用範圍已超越醫療領域，協助實現全球循環經濟目標。與低產量、高利潤的醫療產業不同，此趨勢的特徵是聚乳酸（PLA）等材料的大規模工業化生產，推動一次性產品中化石基塑膠的替代方案。領先的製造商正積極籌集資金籌措，以增強產能，並鞏固向可堆肥替代品的轉型，從而最大限度地減少環境殘留。例如，在2024年5月題為「Ingeo PLA生產擴建計畫獲得創紀錄融資」的新聞稿中，NatureWorks宣布已獲得126億泰銖的企業聯合貸款，用於在泰國建設一座全新的全整合生物聚合物生產基地，從而確保非醫療應用領域的穩定供應。

此外，用於高級創傷護理的靜電紡絲奈米纖維的開發代表著一項重大的技術進步，它採用高表面積基質，能夠與癒合環境積極相互作用。與3D列印整形外科植入提供的結構加固不同，這些奈米纖維敷料專為潰瘍和燒燙傷的局部治療而設計，透過精確調節pH值和吸收滲出液，實現感染控制等功能。該技術能夠建構生物工程合成基質，透過最佳化傷口床的酸度來促進傷口癒合。根據發表在2024年10月《醫療產品外包》（Medical Product Outsourcing）雜誌上的報導《Royal Wound-X推出兩項新的創傷治療技術》，該公司的新型“ElectroFiber 3D”支架已被證實可在78小時內將傷口pH值從7.4降低至5.9，有效降低至細菌生長並促進組織再生。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：可吸收（生物可吸收）聚合物的全球市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依類型（農業聚合物、生物聚酯、其他）
    • 依應用領域（整形外科、心臟植入、牙科植入、口服藥物傳輸等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美可吸收（生物可吸收）聚合物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲可吸收（生物可吸收）聚合物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區可吸收（生物可吸收）聚合物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲可吸收（生物可吸收）聚合物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲可吸收（生物可吸收）聚合物市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球可吸收（生物可吸收）聚合物市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Corbion NV
  • Poly-Med, Inc.
  • Foster Corporation
  • Evonik Industries AG
  • KLS-Martin Limited
  • 3d Biotek LLC
  • Degradable solutions AG
  • Koninklijke DSM NV
  • FUTERRO SA
  • Abbott Laboratories Inc

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 3828

The Global Resorbable (Bioresorbable) Polymers Market is projected to expand from USD 483.43 Million in 2025 to USD 644.52 Million by 2031, reflecting a compound annual growth rate of 4.91%. These specialized biodegradable materials are engineered to decompose safely within the human body, effectively negating the necessity for secondary surgeries to remove hardware after tissues have healed. Key drivers accelerating this market growth include the increasing incidence of chronic diseases within an aging global population and a growing inclination toward minimally invasive medical techniques. In applications such as orthopedic fixation and controlled drug delivery, these polymers offer a distinct clinical benefit over permanent metal implants by providing temporary structural support before being naturally metabolized.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 483.43 MIllion
Market Size 2031USD 644.52 MIllion
CAGR 2026-20314.91%
Fastest Growing SegmentOrthopedics
Largest MarketNorth America

Despite strong demand, the industry faces substantial hurdles related to the rigorous and expensive regulatory procedures needed for medical-grade certification. Manufacturers are required to maneuver through complicated compliance frameworks, which often results in delays to product commercialization. According to European Bioplastics, the global production capacity for bioplastics-including essential resorbable materials like polylactic acid-reached roughly 2.47 million tonnes in 2024. Although this figure suggests a robust supply chain, the strict demands for clinical validation continue to restrict the pace at which innovative polymer technologies can penetrate the medical sector.

Market Driver

The transition from metallic to bioresorbable medical implants is fundamentally transforming the market by eliminating the need for secondary surgical procedures to remove hardware. Because these polymers degrade harmlessly inside the body, they eradicate the clinical risks and healthcare expenditures associated with the follow-up extraction surgeries often required for titanium or steel implants. This distinct clinical advantage is fostering significant adoption in sports medicine and orthopedic fixation, where temporary reinforcement is adequate for bone recovery. Validating this accelerated industrial demand, Corbion reported in its 'Annual Report 2023' in March 2024 that its biomedical polymers division sustained a double-digit growth trajectory, highlighting the rising need for resorbable materials in trauma management and controlled release sectors.

Concurrently, technological advancements in scaffolding and 3D bioprinting are driving market growth by facilitating the production of highly personalized tissue constructs. Advanced additive manufacturing enables the fabrication of porous resorbable structures designed to simulate natural soft tissue, thereby promoting regeneration prior to metabolization. According to a press statement by BellaSeno in August 2024 regarding its clinical program, the safety and efficacy of these next-generation implants were demonstrated through the successful treatment of 41 patients with the company's 3D-printed resorbable scaffolds. The broader industrial landscape supports this scalability, as the Plastics Industry Association estimated in 2024 that North America alone contributed 18.7% of the global bioplastics production capacity, ensuring a reliable material supply for these burgeoning medical technologies.

Market Challenge

The expensive and stringent regulatory process required to obtain medical-grade certification stands as a major barrier to the expansion of the Global Resorbable (Bioresorbable) Polymers Market. Manufacturers must navigate a compliance landscape that is becoming increasingly intricate, particularly under stricter frameworks that necessitate comprehensive technical documentation and clinical data. This regulatory environment imposes a significant financial load and extends the time-to-market for new polymer-based devices, which directly inhibits innovation and discourages market entry for smaller companies lacking the capital to manage these prolonged processes.

The consequences of these elevated standards are both severe and quantifiable. According to MedTech Europe, certification and maintenance costs under the Medical Device Regulation surged by up to 100% in 2024 compared to earlier directives. Such escalating costs and extensive delays force organizations to redirect capital from research and development efforts toward compliance obligations. As a result, the deployment of advanced resorbable polymer technologies is slowed, limiting their commercial availability and suppressing overall market momentum, even in the face of underlying clinical demand for these materials.

Market Trends

The utilization of bioresorbable polymers is gaining momentum in sustainable packaging as the market expands beyond medical uses to meet global circular economy goals. In contrast to the low-volume, high-margin medical industry, this trend is defined by a massive industrial scaling of materials such as polylactic acid (PLA) to supersede fossil-based plastics in single-use products. Leading producers are obtaining significant capital to enhance manufacturing capacities, confirming the transition toward compostable alternatives that minimize environmental persistence. For instance, NatureWorks announced in a May 2024 press release titled 'Ingeo PLA Manufacturing Expansion Attracts Record Financing' that it had secured a syndicated loan of 12.6 billion THB to finance a new fully integrated biopolymer manufacturing complex in Thailand, ensuring a steady supply for these non-medical applications.

Furthermore, the development of electrospun nanofibers for advanced wound care marks a crucial technical evolution, employing high-surface-area matrices to actively influence the healing environment. Unlike the structural reinforcement offered by 3D-printed orthopedic implants, these nanofibrous dressings are engineered for the topical treatment of ulcers and burns, providing functions such as infection control and exudate absorption via precise pH regulation. This technology facilitates the generation of bioengineered synthetic matrices that hasten closure rates by optimizing the acidity of the wound bed. According to an October 2024 article in Medical Product Outsourcing titled 'Royal Wound-X Launches Two New Wound Healing Technologies', the company's new ElectroFiber 3D scaffold proved capable of lowering wound pH from 7.4 to 5.9 within 78 hours, effectively inhibiting bacterial growth while encouraging tissue regeneration.

Key Market Players

  • Corbion NV
  • Poly-Med, Inc.
  • Foster Corporation
  • Evonik Industries AG
  • KLS-Martin Limited
  • 3d Biotek LLC
  • Degradable solutions AG
  • Koninklijke DSM N.V.
  • FUTERRO S.A.
  • Abbott Laboratories Inc

Report Scope

In this report, the Global Resorbable (Bioresorbable) Polymers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Resorbable (Bioresorbable) Polymers Market, By Type

  • Agro-Polymers
  • Biopolyesters
  • Others

Resorbable (Bioresorbable) Polymers Market, By Application

  • Orthopedics
  • Cardiac Implants
  • Dental Implants
  • Oral Drug Delivery
  • Others

Resorbable (Bioresorbable) Polymers Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Resorbable (Bioresorbable) Polymers Market.

Available Customizations:

Global Resorbable (Bioresorbable) Polymers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Resorbable (Bioresorbable) Polymers Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Agro-Polymers, Biopolyesters, Others)
    • 5.2.2. By Application (Orthopedics, Cardiac Implants, Dental Implants, Oral Drug Delivery, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Resorbable (Bioresorbable) Polymers Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Resorbable (Bioresorbable) Polymers Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Resorbable (Bioresorbable) Polymers Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Resorbable (Bioresorbable) Polymers Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Resorbable (Bioresorbable) Polymers Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Resorbable (Bioresorbable) Polymers Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Resorbable (Bioresorbable) Polymers Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Resorbable (Bioresorbable) Polymers Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Resorbable (Bioresorbable) Polymers Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Resorbable (Bioresorbable) Polymers Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Resorbable (Bioresorbable) Polymers Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Resorbable (Bioresorbable) Polymers Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Resorbable (Bioresorbable) Polymers Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Resorbable (Bioresorbable) Polymers Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Resorbable (Bioresorbable) Polymers Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Resorbable (Bioresorbable) Polymers Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Resorbable (Bioresorbable) Polymers Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Resorbable (Bioresorbable) Polymers Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Resorbable (Bioresorbable) Polymers Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Resorbable (Bioresorbable) Polymers Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. South America Resorbable (Bioresorbable) Polymers Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Resorbable (Bioresorbable) Polymers Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Resorbable (Bioresorbable) Polymers Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Resorbable (Bioresorbable) Polymers Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Resorbable (Bioresorbable) Polymers Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Corbion NV
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Poly-Med, Inc.
  • 15.3. Foster Corporation
  • 15.4. Evonik Industries AG
  • 15.5. KLS-Martin Limited
  • 15.6. 3d Biotek LLC
  • 15.7. Degradable solutions AG
  • 15.8. Koninklijke DSM N.V.
  • 15.9. FUTERRO S.A.
  • 15.10. Abbott Laboratories Inc

16. Strategic Recommendations

17. About Us & Disclaimer